Thrombosis

Review Article

The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty

Table 1

Description of RECORD trials comparing rivaroxaban to enoxaparin for VTE prophylaxis in patients undergoing THA and TKA.
ProcedureRECORD 1RECORD 2RECORD 3RECORD 4
THATHATKATKA
Rivaroxaban dose10 mg daily10 mg daily10 mg daily10 mg daily
Enoxaparin dose40 mg daily40 mg daily40 mg daily30 mg BID
Treatment duration (days)31–39Enoxaparin 10–14, rivaroxaban 31–3910–1410–14
Patients ( )4541250925313148